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Background: Low back pain (LBP) is a prevalent condition and a socioeconomic problem in many countries. Due
to its recurrent nature, the prevention of further episodes (secondary prevention), seems logical. Furthermore, when
the condition is persistent, the minimization of symptoms and prevention of deterioration (tertiary prevention), is
equally important. Research has largely focused on treatment methods for symptomatic episodes, and little is
known about preventive treatment strategies.
Methods/Design: This study protocol describes a randomized controlled clinical trial in a multicenter setting
investigating the effect and cost-effectiveness of preventive manual care (chiropractic maintenance care) in a
population of patients with recurrent or persistent LBP.
Four hundred consecutive study subjects with recurrent or persistent LBP will be recruited from chiropractic clinics
in Sweden. The primary outcome is the number of days with bothersome pain over 12 months. Secondary
measures are self-rated health (EQ-5D), function (the Roland Morris Disability Questionnaire), psychological profile
(the Multidimensional Pain Inventory), pain intensity (the Numeric Rating Scale), and work absence.
The primary utility measure of the study is quality-adjusted life years and will be calculated using the EQ-5D
questionnaire. Direct medical costs as well as indirect costs will be considered.
Subjects are randomly allocated into two treatment arms: 1) Symptom-guided treatment (patient controlled),
receiving care when patients feel a need. 2) Preventive treatment (clinician controlled), receiving care on a regular
basis. Eligibility screening takes place in two phases: first, when assessing the primary inclusion/exclusion criteria,
and then to only include fast responders, i.e., subjects who respond well to initial treatment. Data are collected at
baseline and at follow-up as well as weekly, using SMS text messages.
Discussion: This study investigates a manual strategy (chiropractic maintenance care) for recurrent and persistent
LBP and aims to answer questions regarding the effect and cost-effectiveness of this preventive approach. Strict
inclusion criteria should ensure a suitable target group and the use of frequent data collection should provide an
accurate outcome measurement. The study utilizes normal clinical procedures, which should aid the transferability
of the results.
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Trial registration: Clinical trials.gov; NCT01539863, February 22, 2012. The first patient was randomized into the
study on April 13th 2012.
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Low back pain (LBP) is a major public health problem in
many countries with resulting consequences both for the
individual and society. The total cost of LBP in Sweden
was estimated at €1,840 million in 2001 [1]. Interven-
tions that reduce the prevalence of back pain would
therefore contribute to improvements on a public health
level and potentially have large economic benefits.
LBP has been shown to be a recurrent and sometimes
persistent phenomenon [2,3]. Logically, a recurrent and
sometimes persistent condition that is highly prevalent in-
vites the idea of prevention. However, knowledge about
secondary prevention, to decrease the rate of recurrence,
and tertiary prevention, to decrease the intensity or extent
of persistent pain for this condition is scarce [4].
In Sweden, LBP is the condition for which most people
seek care from a chiropractor [5,6]. Manual treatment,
which has been shown to be effective for some patients
[4], is a major treatment component. Among chiroprac-
tors, the traditionally employed long-term approach for
individuals with recurrent or persistent pain is a prevent-
ive protocol described as maintenance care (MC) [7-10].
Early authors have described MC as “…a regimen designed
to provide for the patient’s continued well-being or for
maintaining the optimum state of health while minimizing
recurrences of the clinical status” [11] and “…treatment, ei-
ther scheduled or elective, which occurred after optimum
recorded benefit was reached, provided there was no evi-
dence of relapse” [12].
A 2008 systematic review concluded that chiropractic
MC lacked an evidence-based definition as well as
evidence-based indications, frequency, and content of
treatment [13]. However, since 2009, several studies have
investigated the frequency and content of this preventive
strategy. As suggested by the name, the aim of the treat-
ment is to maintain a certain treatment effect (i.e., less
pain or improved function) [7], and care is normally de-
livered at widely spaced but regular intervals over a fairly
long time [14,15].
Research during 2009 and 2010 has also concluded
that there seems to be a general management concept
within the chiropractic profession in the Scandinavian
countries with regards to secondary and tertiary preven-
tion [7,9,10,16]. In Sweden, 98% of chiropractors who
have an academic education use some form of MC [7].
This type of care is in part proactive, i.e., the clinicianwill encourage the patient to perform specific exercises
or a training program. Typically, one will also attempt to
influence the LBP problem in other ways through dis-
cussions about life style [14]. Thus, regular visits may
have a supportive psychosocial function by aiding coping
strategies and providing support and guidance. Manual
therapy (such as spinal manipulation or mobilization) of
the musculoskeletal system is included as needed, as
judged by the clinician [14,17,18].
A few studies have been published on the effect of pre-
ventive spinal manipulation on spinal pain and the re-
sults have been equivocal [5,19,20], maybe due to the
fact that these were small studies that did not employ
the evidence regarding indications for care in their inclu-
sion process, nor regarding frequency and treatment
content in their instructions for care. Thus, more re-
search is needed to determine the effect and cost-
effectiveness of this preventive package of care. In par-
ticular, it would be important to select study subjects in
accordance with the procedures that have developed
from years of professional experience and to include the
treatment programs and activities that chiropractors ac-
tually use for this type of therapeutic strategy. This study
makes use of the available evidence in the field.
Methods/Design
Study aim
The study aims to investigate the effect, cost-effectiveness,
and cost-utility of preventive manual care as compared to
manual care given only when there is a subject-perceived
need in a population of patients with recurrent or persist-
ent LBP. The primary outcome is the number of days with
bothersome pain on which the cost-effectiveness calcula-
tions will also be performed. Thus, the null hypothesis will
be that the subjects in the two treatment arms will report
equal numbers of days with bothersome pain.
Setting
Forty Swedish chiropractors will collect data on con-
secutive patients with recurrent or persistent LBP. The
clinicians recruited for this study have participated in a
previous study regarding the use of preventive care [8]
and have experience of how to integrate research into
clinical practice. Only clinicians who reported that they
use preventive care selectively were recruited. This was
thought to minimize the clinicians’ bias towards either
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describing the project in detail, was given to the clini-
cians in a small group seminar format. Following the
seminar, a member of the research team has been con-
ducting weekly follow-ups by telephone with the partici-
pating clinicians to ensure that the procedures are
followed according to the project outline and that the
data collection is performed correctly.
Eligibility criteria
The inclusion criteria for study subjects are: presenting
with LBP as the main complaint, recurrent LBP (the in-
dividual has experienced episodes of LBP in the past), or
persistent LBP (more than 30 days over the past year
[21]). A minimum of three months must have passed
since the last treatment by a chiropractor if previously
treated. This interval was chosen as research indicates
that the treatment seems to have little effect after three
months [22]. This was also consistent with the research
team’s clinical experience. The subjects must be of work-
ing age (18 to 65 years), have access to a mobile phone
and knowledge of how to receive and send text-
messages (SMS), as well as be proficient in Swedish.
Subjects must rate themselves as “definitely improved”
by the fourth visit [23]. The exclusion criteria for pa-
tients are: pregnancy, acute trauma, cancer, infection,
cauda equina, osteoporosis, and vertebral fractures. Fur-
ther, subjects with completely subsidized treatment from
a third party payer, such as injury compensation [24],
local county council subsidization, or workplace benefits,
are excluded from the study. The majority of the chiro-
practic patients in Sweden do not have access to subsi-
dized treatment.
An overview of the eligibility criteria can be found in
Table 1.
Procedures
The study procedures are shown in the flowchart in
Figure 1. To resemble the clinical decision-making
process, the eligibility procedure consists of two main
stages; first, to find possible candidates and second, toTable 1 Eligibility screening
Inclusion criteria
Baseline 1 Age 18 to 65 years
LBP with or without leg pain for more than 30 days during th
Previous episodes
Access to a mobile phone
Ability to send and receive SMS (text messages)
Baseline 2 Self-rated “definitely improved” by the fourth treatment
Study start Interval between treatments is one month or more
LBP, Non-specific low back pain.select only the study subjects who respond favorably to
treatment. According to previous research, this is con-
gruent with the procedure used by chiropractors when
making clinical decisions regarding MC [7,10].
For the initial visit, patients are instructed to arrive
15 minutes early if perceived as possible candidates for
the study (i.e., presenting with LBP) when the booking is
made. Upon arrival before the initial visit, the patients
fill in a questionnaire, baseline 1, along with a screening
form with inclusion/exclusion criteria with descriptive
data. If no exclusion criteria exist, the patients are then
treated as usual up until the fourth visit.
A continuous assessment regarding the response to
treatment is made at each visit and recorded in the pa-
tients’ files. If the patients consider themselves “definitely
improved” according to the global perceived improve-
ment scale (single question with answer options defin-
itely worse, probably worse, unchanged, probably better,
definitely better) by the fourth visit or earlier, they are
candidates for the study. During the fourth visit, or prior
if “definitely improved”, the questionnaires of baseline 2
are administered.
The patients continue with treatment until the clin-
ician considers them well enough to extend the interval
between treatments to one month or longer. Clinically,
the study subjects then enter the MC phase and data
collection can commence, i.e., the study starts. The po-
tential subjects are informed of the study procedure and
asked to sign a letter of informed consent should they
wish to participate. Subjects are then randomly allocated
into one of two treatment arms; symptom guided treat-
ment (patient controlled) or preventive/MC treatment
(clinician controlled).
If patients do not improve to the point where the
interval between treatments can be extended to at least
one month, they are not eligible to continue in the study
and are excluded. The cut-off interval of one month was
decided after discussions within the research team based
on their collective clinical experience. A time interval of
less than one month was considered an active treatment
regimen; this is also supported by a 2010 study [15].Exclusion criteria
Pregnancy
e past year Chiropractic treatment less than 3 months ago
Completely subsidized treatment from third party payer
Serious pathology (i.e., acute trauma, cancer, infection,
cauda equina, osteoporosis, vertebral fractures) or
contraindications to manual therapy
Self-rated improvement being anything but
“definitely improved” by the fourth treatment
Interval between treatments never extends to one month
Follow-up after 12 
months
Weekly text messages 
over 12 months
Study start 
Random allocation
Baseline 2, 4th visit (or 
earlier depending on 
improvement)            
Baseline 1, first visit     Patients  with LBP screened for eligibility
Screen to find  the  patients who have definitely 
improved
Suitable study candidates
Symptomatic treatment, 
patient  controlled  
Follow-up 
Preventive treatment, 
clinician controlled
Follow-up
Exclusion: 
treatment 
always 
scheduled 
less than 1 
month 
apart 
Exclusion: 
not def 
improved
Exclusion: 
age, red 
flags, etc
Eligibility screening
6-8 months to 
include 400 
study subjects
Study period
12 months
Figure 1 Study procedures.
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treatments in an MC-regimen is two months [14]. How-
ever, a systematic review concluded that it was difficult
to evaluate the effect of treatments more than three
months apart [22]. The participating clinicians are there-
fore allowed to choose an interval between treatments of
a minimum of one and a maximum of three months
apart.
During the study period, study subjects in the two
treatment arms continue treatment according to each
protocol. The study period lasts 12 months. The treat-
ments during these 12 months are offered with a re-
duced treatment fee of 50% for subjects in both
treatment arms, but only for visits regarding LBP.
Randomization procedure
Consecutively numbered opaque envelopes containing a
letter with instructions are created off-site at the re-
search center by a statistician and a research assistant. A
1:1 allocation ratio in randomly permuted blocks of dif-
ferent sizes according to a randomization schedule is
used. SPSS v20 was used to generate the randomization
code. The envelopes are opened consecutively in the
presence of the study subjects as they become eligible
for the study and give consent to participate.
Blinding
The randomization is blinded to the study team in order
not to influence the clinicians during the workshops and
in personal contact during the inclusion process. The
data collecting clinicians are unaware of the individual
allocation of their patient until they have opened the en-
velope after consent is given. Due to the treatment mo-
dality, study subjects and clinicians cannot be blinded to
the treatment.Sample size
A power analysis has estimated the number of subjects
needed to detect a change in treatment effect of 30% (i.e.,
30% fewer days of bothersome LBP) to be 177 in each
treatment arm. The 30% cut-off point was decided to be a
clinically important difference with regards to number of
days of bothersome pain. Furthermore, a 20% (for acute
pain) and 30% (for chronic pain) change in intensity mea-
sured on NRS-11 has been shown to be a clinically mean-
ingful change [25,26].
In previous Swedish intervention studies among this
group of chiropractors, compliance has been around 70
to 80% [27,28]. With a similar compliance rate in this
study, we would need to include 400 study subjects
when allowing for dropouts.Treatment arms
Each clinician is instructed to describe the two different
treatment approaches as similar procedures, clinically
both in use, when informing potential study subjects.
The clinicians are asked to describe the aim of the study
as a sincere wish to investigate if any of the two treat-
ment modalities is more effective.Symptom guided treatment (patient controlled)
Study subjects in the first treatment arm receive treat-
ment according to their perceived needs, i.e., they are
advised to seek care when the LBP returns, gets worse,
or starts to affect their functional capacity. When seek-
ing care, they get treated according to the clinicians’
judgments. As soon as the subjects are symptom-free or
satisfied with the improvement, the treatment is discon-
tinued, but can recommence should new symptoms ap-
pear. Thus, subjects in this group are therefore treated
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treatment arm is described as “patient controlled”.
Preventive treatment (clinician controlled)
Study subjects in the second treatment arm receive pre-
ventive treatment according to the clinicians’ judgments,
i.e., they are instructed to follow a treatment plan de-
signed to minimize the recurrence of the pain/dysfunc-
tion or to maintain the effect of the initial treatment. In
this group, the clinicians’ responsibility is to be proactive
and to plan a preventive treatment strategy. This group
is described as the “clinician controlled” treatment arm
or the MC group. Visits are scheduled at 1 to 3 month
intervals according to the clinicians’ judgments. If the
subjects relapse before the next scheduled visit, they are
instructed to seek care and are treated according to the
clinical picture until they are symptom-free or satisfied
with the improvement, after which they return to the
original MC plan. The total number of treatments will
be the sum of scheduled and acute visits.
For all study subjects, treatment content is decided by
the treating clinician and the two arms will experience
the same “individualized” care with regards to modalities
and recommendations. Treatment content is noted in
detail in the patients’ files.
Outcome measures
The primary outcome of the study is the number of days
with bothersome pain over 12 months. The term bother-
someness has previously been used as a measurement
for the impact of pain [29-31]. The term has been shown
to correlate well with self-rated health [32], pain inten-
sity [33], disability, psychological health (anxiety, depres-
sion), and prediction of future work absence/healthcare
consultations [34], and has been suggested as a standard
outcome measure in LBP research [31].
During the follow-up time of 12 months, all partici-
pants receive weekly text messages by the SMS-Track
system [35,36] asking “How many days during the previ-
ous week has your low back pain been bothersome (i.e.,
affected your daily activities or routines)? Please answer
with a number between 0 and 7” (requiring an answer
between 0–7, sent in a reply text message). This ques-
tion has not been validated against other instruments;
however, it has been used in previous studies [2,27,37] in
similar settings in Sweden and Denmark and has been
found useful for collecting data to examine the clinical
course of LBP in the primary care sector. Should the
subjects fail to respond, a subsequent SMS is sent after
48 hours with a reminder. If the participants fail to re-
spond to this second SMS, a research assistant will
follow-up with a phone call to investigate the reason for
non-compliance and to provide further instructions if
necessary.Secondary measures consist of self-rated health (EQ-
5D [38,39], a translated (Swedish) and validated ques-
tionnaire with five domains and three answer options in
each), activity limitation (the Roland Morris Disability
Questionnaire, RMDQ [40], a translated (Swedish) and
validated questionnaire with 24 items requiring a yes/no
response), pain intensity (the Numeric Rating Scale,
NRS-11 [41,42]), psychological/behavioral characteristics
(the West Haven-Yale Multidimensional Pain Inventory
(MPI), [43-45], a translated (Swedish) and validated 34-
item, 8 scales inventory divided into two parts), self-
reported work absence [46] (single question, translated
(Swedish) and validated) (Table 2), and work productiv-
ity (single question, based upon the validated but not
translated WPAI-instrument (LBP–V2-Swedish) [47])
(Table 2).
The secondary outcomes will be analyzed and reported
independently of the primary outcome.
The primary utility measure of the study is quality-
adjusted life years [38], and will be calculated using the
EQ-5D questionnaire.
Baseline and follow-up assessments
Baseline data at the initial visit (baseline 1) include
demographic data (Table 2), pain intensity over the last
24 hours (NRS-11) [41,42], self-rated health (EQ-5D)
[38], and the assessment of psychological profiles with
the Multidimensional Pain Inventory, Swedish version
(MPI-S) [43]. MPI-S will be used in a secondary analysis
to investigate the potential interaction between the MPI
subgroup and treatment effect.
During the fourth visit (or earlier if pain-free or well
enough to discontinue care) (baseline 2), the subjects’
globally perceived improvement is measured using a 5-
step scale (definitely worse, probably worse, unchanged,
probably better, definitely better) [23] along with a
follow-up NRS-11 [41,42] (for pain intensity over the
past 24 hours). To assess clinicians’ expectations, the cli-
nicians also state if they believe that their patient’s prob-
lem would benefit from preventive treatment (yes/no
question).
Further baseline data are collected at the time of
randomization. At that time, data regarding activity limi-
tation (RMDQ [40]), physical work load, self-reported
work absence [46], treatment content, and number of
treatments are collected.
At the end of the study, both clinicians and study sub-
jects receive a follow-up questionnaire (Table 2). The cli-
nicians are asked to review the clinical files for
treatment frequency, content, and any side-effects or ad-
verse reactions associated with the treatment. The study
subjects are asked about their pain intensity [41,42], ac-
tivity limitations [40], general health [48], work absence
[46] and satisfaction with care. To describe work
Table 2 Assessment instruments and procedures
Time Instruments Detailed description
First visit/baseline 1 EQ-5D Self-rated health [38]
MPI-S Psychological profile [43-45]
NRS-11 Pain intensity last 24 hours [41,42]
Descriptive data (subject) Pregnancy (yes/no)
Year of birth
Pain in low back (yes/no)
Pain in leg (yes, thigh only/yes, thigh and shin/no)
Previously visited chiropractor
(no/yes, more than 3 months ago/yes, less than 3 months ago)
Past episodes of LBP (yes/no)
Days in total with LBP during past year (<30/≥30)
Pain in cervical or thoracic spine (no/yes, ≥30 days past year/yes,
<30 days past year)
Access to mobile phone (yes/no)
Ability to send SMS text messages (yes/no)
Belief in chance of improvement by treatment
(NRS-11 varying from no chance to very probable)
Subjective perception of health in general
(5-step scale, perfect, very good, good, fair, poor)
Baseline 2, fourth visit or
earlier if indicated
NRS-11 Pain intensity last 24 hours [41,42]
Descriptive data (subject) Subjective perception of health in general
(5-step scale, perfect, very good, good, fair, poor)
Descriptive data (clinician) Clinician’s expectations concerning the response
to preventive treatment
Study start (When next visit can be
scheduled at least one month ahead)
RMDQ Self-rated disability [40]
Descriptive data (subject) Sex (man/woman)
Year of birth
Profession (physically heavy labor/interchanging
between heavy and light/ standing and walking/sitting)
Self-reported work absence Sick leave during past year (no/yes, 1–7 days in total/yes,
8–14 days in total/yes, ≥15 days in total)
Descriptive data (clinician) Type of treatment so far (manipulation, mobilization,
activator, drop/soft tissue treatment/information,
recommendations/other, as described by the chiropractor)
Number of treatments during the past episode
Random allocation
Study period Weekly data collection for
52 weeks collected with
SMS (text messages)
“How many days during the previous week has your
low back pain been bothersome (i.e., affected your daily
activities or routines)? Please answer with a number between
0 and 7” (requiring an answer between 0–7,
sent in a reply text message [35,36])
Follow-up after 12 months EQ-5D Self-rated health [38]
RMDQ Self-rated disability [40]
NRS-11 Pain intensity last 24 hours [41,42]
Descriptive data (subject) Other treatment in the past year? If yes, which type
(physiotherapist, other chiropractor, medical doctor,
medication, other)?/No
Treatment value: considering economy, time consumption,
LBP, function, quality of life, is the treatment worth continuing with?
(5-step scale, definitely worth it, possibly worth it, equivocal,
hardly worth it, definitely not worth it)
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Subjective perception of health in general
(5-step scale, perfect, very good, good, fair, poor)
Self-reported work absence Sick leave during past year (no/yes, 1–7 days in total/yes,
8–14 days in total/yes, ≥15 days in total)
Modified WPAI-LBP Work productivity (How much has your low back pain
affected your productivity during the past month, while at work?
NRS-11 varying from LBP did not affect my work to LBP
completely prevented me from working)
Descriptive data (clinician) Number of treatments including date
Type of treatment so far (manipulation, mobilization, activator,
drop/soft tissue treatment/information, recommendations/other,
as described by the chiropractor)
Reported side-effects (local soreness, fatigue,
new radiating pain, other) including duration
EQ-5D, EuroQol 5 Dimensions; LBP, Non-specific low back pain; MPI-S, Multidimensional pain inventory, Swedish version; NRS-11, Numerical rating scale (11 steps,
0–10); RMDQ, Roland Morris Disability Questionnaire; WPAI-GH, Work productivity and activity impairment questionnaire – general health.
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impairment questionnaire, WPAI-instrument (LBP–V2-
Swedish) [47] (How much has the pain affected product-
ivity during past working month?) is used.
Time line
The inclusion of study subjects started in April 2012 and
is expected to proceed for a 24-month period due to the
extensive inclusion protocol. The study per se runs over
the course of 12 months and data collection is expected
to be concluded during April 2015.
Analysis
Data analysis of the primary outcome “number of days
with bothersome LBP”
Intention-to-treat [49] will be used to test the null hypoth-
esis as described in the study aim. Outcome measures will
not be imputed for participants not responding to follow-
up questions as previous research using the SMS-Track
system has yielded high response rates [33,36,37] and re-
search has indicated it unnecessary when performing ana-
lysis on longitudinal data [50]. Patient related outcomes
measured at the fourth visit, weekly during the study
period, and at the end of the study at 12 months will be
evaluated using general [51] or generalized linear models
[52-54] with mean baseline values as covariates. Sex, age,
the presence of leg pain, patient expectations, pain inten-
sity, the use of painkillers, sickness, albescence, type of
profession, and number of treatments before being in-
cluded in the study will be considered as possible con-
founders. All available data will be used for data analysis.
A dropout analysis will be performed to compare the
study population with dropouts regarding descriptive data.
Additional analyses of secondary outcomes will be per-
formed in an explorative manner.
An analysis of cost-effectiveness and cost-utility will be
performed with consideration to both the individual andsocietal perspectives [55]. The cost-effectiveness will be
determined by comparing the incremental cost effective-
ness ratio in regard to the primary effectiveness measure
between the two study arms [55]. Both the incremental
cost effectiveness ratio and the incremental cost-utility
ratio will be calculated by dividing the difference in
mean total costs by the difference in the outcome of
interest between the two treatment arms. Direct medical
costs considered in the study are treatment cost (treat-
ment fee) as well as time loss during treatment and
travel (an average time for travel is estimated and added
to an average patient visit time). Indirect costs such as
production loss will be estimated using the human cap-
ital approach where lost time is valued using the hourly
wage [56]. Since the data collection is performed be-
tween 2011 and 2014, all costs will be adjusted for infla-
tion using a 3 to 5% inflation rate with the baseline year
of the study as a base year [55] and calculated in €.
Ethical aspects
The study will be conducted according to the guidelines
of the Helsinki declaration [57] and good clinical re-
search practice [58]. The project has been approved by
the local ethical research committee at the Karolinska
Institutet: 2007/1458-31/4. There is a risk that patients
in the patient controlled arm could experience relapses
that could have been prevented if an experienced clin-
ician had decided on preventive treatment. Further, it is
possible that the clinician-guided arm may have a nega-
tive impact on patients’ illness perceptions or empower-
ment. However, neither of the treatment arms differs
from what the study subjects would have received
should they not have participated in the study.
Discussion
Although LBP is and has been a challenge for society for
many years, little is known about the preventive strategies
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management culture with a preventive intent towards re-
current and persistent LBP. For the individual patient, the
possibility of preventing episodes may be very beneficial
and help keep the individual active. Furthermore, the abil-
ity to control symptoms and their effects on everyday life
may be paramount. However, a preventive treatment with
potential side effects and related costs can only be justified
if it is demonstrated to have clinically worthwhile effects.
To date, there has been no large scale randomized
clinical trial comparing chiropractic MC for LBP with
symptom-guided treatment. This study will utilize avail-
able evidence in the field for the selection of study sub-
jects, frequency of treatment, and treatment content.
Furthermore, the study mimics the usual clinical proce-
dures of chiropractic care, which will aid the transfer-
ability of the study results.
Trial status
The trial is ongoing and patients are being recruited. Pa-
tient recruitment started in April 2012 and is expected
to continue until April 2014.
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